- Company Overview for INFUSIVE MD LIMITED (10667316)
- Filing history for INFUSIVE MD LIMITED (10667316)
- People for INFUSIVE MD LIMITED (10667316)
- More for INFUSIVE MD LIMITED (10667316)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 May 2019 | RP04CS01 | Second filing of Confirmation Statement dated 12/03/2019 | |
17 May 2019 | RP04CS01 | Second filing of Confirmation Statement dated 12/03/2018 | |
08 May 2019 | AA | Full accounts made up to 31 December 2018 | |
28 Mar 2019 | CS01 |
Confirmation statement made on 12 March 2019 with no updates
|
|
28 Aug 2018 | AA01 | Current accounting period shortened from 31 March 2019 to 31 December 2018 | |
27 Jun 2018 | AA | Accounts for a dormant company made up to 31 March 2018 | |
31 May 2018 | AD01 | Registered office address changed from 38 Berkeley Square London W1J 5AE United Kingdom to 30 Panton Street London SW1Y 4AJ on 31 May 2018 | |
31 May 2018 | AP01 | Appointment of Mr Conrad Levy as a director on 3 May 2018 | |
31 May 2018 | AP01 | Appointment of Mr Andrea Ruggeri as a director on 3 May 2018 | |
31 May 2018 | AP04 | Appointment of Bcs Cosec Limited as a secretary on 3 May 2018 | |
04 Apr 2018 | CS01 |
Confirmation statement made on 12 March 2018 with updates
|
|
04 Apr 2018 | PSC07 | Cessation of Infusive Plc as a person with significant control on 10 December 2017 | |
04 Apr 2018 | PSC01 | Notification of Philip George Haretos as a person with significant control on 10 December 2017 | |
13 Mar 2017 | NEWINC |
Incorporation
Statement of capital on 2017-03-13
Statement of capital on 2019-05-17
|